Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SOLV
SOLV logo

SOLV Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Solventum Corp (SOLV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
73.380
1 Day change
2.41%
52 Week Range
88.200
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Solventum Corp (SOLV) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows mixed signals with no significant positive catalysts to justify immediate entry, despite some long-term potential. Holding or waiting for further clarity in market trends and performance would be more prudent.

Technical Analysis

The MACD is positive at 0.626 but contracting, indicating weakening bullish momentum. RSI is neutral at 58.569, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 68.442, with resistance at 70.845 and support at 66.039. Overall, technical indicators suggest a neutral stance.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
10

Positive Catalysts

  • Analysts from KeyBanc and UBS have expressed optimism about the company's long-term potential, citing steady progress toward 2028 targets and an offensive capital allocation strategy. Additionally, net income and EPS have shown significant YoY growth in the latest quarter.

Neutral/Negative Catalysts

  • Revenue and gross margin have declined YoY, indicating potential operational challenges. Analysts like Rothschild & Co have expressed concerns about the company's ability to accelerate organic growth due to its focus on mature and competitive markets. No recent news or significant insider/hedge fund activity provides additional support for the stock.

Financial Performance

In Q4 2025, revenue dropped by -3.71% YoY to $1.998 billion, while net income increased by 103.23% YoY to $63 million. EPS doubled to 0.36, but gross margin declined by -4.69% YoY to 51.4%. The financials show mixed performance, with profitability improving but operational efficiency declining.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst ratings are mixed. Piper Sandler and BTIG have lowered their price targets recently, though they maintain Overweight and Buy ratings, respectively. KeyBanc remains optimistic with a $97 price target, while Rothschild & Co has a Sell rating with a $60 price target, citing structural challenges in the business. The consensus reflects uncertainty about the company's growth trajectory.

Wall Street analysts forecast SOLV stock price to rise
8 Analyst Rating
Wall Street analysts forecast SOLV stock price to rise
5 Buy
3 Hold
0 Sell
Moderate Buy
Current: 71.650
sliders
Low
79
Averages
93.71
High
105
Current: 71.650
sliders
Low
79
Averages
93.71
High
105
UBS
Kevin Caliendo
Neutral
downgrade
$82 -> $78
AI Analysis
2026-05-06
New
Reason
UBS
Kevin Caliendo
Price Target
$82 -> $78
AI Analysis
2026-05-06
New
downgrade
Neutral
Reason
UBS analyst Kevin Caliendo lowered the firm's price target on Solventum to $78 from $82 and keeps a Neutral rating on the shares.
Stifel
Buy
downgrade
$105 -> $90
2026-05-06
New
Reason
Stifel
Price Target
$105 -> $90
2026-05-06
New
downgrade
Buy
Reason
Stifel lowered the firm's price target on Solventum to $90 from $105 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SOLV
Unlock Now

People Also Watch